Rhythm Biosciences Ltd has released a press release.
Strong Demand in Share Placement to Raise $3.5 million
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
In the deck
Story so far
Earlier from Rhythm Biosciences
- Receipt of Research & Development Tax Incentive
- 2nd Generation, ColoSTAT Multiplex Alpha Kit Outperforms
- Board Renewal / Composition Update
- Platform Expansion - Gastric Cancer Diagnostic Test Update
- Product and Market Update - Phase 2 Milestone
Later from Rhythm Biosciences
- Market Update - All End of CY24 Milestones Attained
- Pause in Trading
- RHY Acquires Genetype Genetic Risk Assessment Business
- Completion of Genetype Risk Assessment Portfolio Acquisition
- About the Genetype Acquisition
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences